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Abstract
The purpose of the present study was to study the mechanisms involved in the induction of apoptosis and by tributyltin
(TBT) in rainbow trout hepatocytes, and to examine the role of intracellular Ca2, protein kinase C (PKC) and proteases in
the apoptotic process. The intracellular Ca2 chelator BAPTA-AM has a suppressive effect on TBT-mediated apoptosis.
However, exposure to the ionophore A23187 is not sufficient to induce apoptosis in trout hepatocytes. The results obtained
also show that TBT stimulates PKC Q and N translocation from cytosol to the plasma membrane in trout hepatocytes after
30 min of exposure. However, PKC Q translocation is down-regulated after 90 min of treatment. The addition of protein
kinase inhibitors (staurosporine and H-7) not only fails to inhibit apoptosis induced by TBT, but also leads to enhancement
of DNA fragmentation. These inhibitors also afford a remarkable protection against the loss of plasma membrane integrity
caused by TBT exposure. PMA, a direct activator of PKC, fails to stimulate DNA fragmentation. In addition, Z-VAD.FMK
is an extremely potent inhibitor of TBT-induced apoptosis in trout hepatocytes, indicating that the activation of ICE-like
proteases is a key event in this process. The cysteine protease inhibitor N-ethylmaleimide also prevented TBT-induced DNA
fragmentation. Taken together, these data allow for the first time to suggest a mechanistic model of TBT-induced apoptosis.
We propose that TBT could trigger apoptosis through a step involving Ca2 efflux from the endoplasmic reticulum or other
intracellular pools and by mechanisms involving cysteine proteases, such as calpains, as well as the phosphorylation status of
apoptotic proteins such as Bcl-2 homologues. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis is an active cellular death process char-
acterized by distinctive morphological changes that
include condensation of nuclear chromatin, cell
shrinkage, nuclear disintegration, plasma membrane
blebbing, and the formation of membrane-bound
apoptotic bodies [1]. A molecular hallmark of apop-
tosis is degradation of the cell’s nuclear DNA into
oligonucleosomal-length fragments as the result of
activation of endogenous endonucleases [2]. In
many cases, cell death by apoptosis requires gene
expression. Genetic studies in the nematode Caeno-
rhabditis elegans have shown that 14 genes are in-
volved in di¡erent steps of the apoptotic pathway
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[3]. The ced-9 gene product is known to protect cells
from death, whereas the ced-3 and ced-4 gene prod-
ucts are required for execution of cell death [4]. It has
been found that Bcl-2 is the mammalian homologue
of ced-9, while the protease interleukin-1L converting
enzyme (ICE) is the mammalian homologue of ced-3
[5].
In contrast to apoptosis, necrosis is an accidental
cell death often caused by toxic agents [6]. Necrosis
di¡ers from apoptosis morphologically and bio-
chemically [2]. Necrosis is characterized by swelling
and bursting of the cell, leading to release of cyto-
plasmic materials into the extracellular space, as well
as by random cleavage of DNA. Furthermore, plas-
ma membrane integrity, which is conserved during
apoptosis, is lost during necrosis. Although toxic
agents have the potential to cause necrosis, some of
them can interfere with intracellular signaling path-
ways and induce apoptosis instead of necrosis.
The water pollutant tributyltin (TBT) is known to
stimulate apoptosis. In previous studies, it has been
reported that TBT induces apoptosis in isolated thy-
mocytes at concentrations which are relevant to
those causing thymus atrophy in vivo [7,8]. TBT
can also induce apoptosis in PC12 cells, in human
T-lymphoblastoid CEM cells, and in tissues of the
marine sponge Geodia cydonium [9,10]. While the
mechanism of TBT-induced apoptosis is still un-
known, it has been reported that TBT stimulates
thymocyte apoptosis by a mechanism independent
of protein synthesis and under conditions where in-
tracellular ATP levels are severely depleted [8]. In
addition, Chow et al. [11] invoke a capacitative
Ca2 entry for TBT-induced cell death. Their report
shows that the increase in the cytosolic free Ca2
concentration ([Ca2]i) occurs through a three-step
mechanism: (i) release of Ca2 from the intracellular
store(s), (ii) inhibition of the Ca2 extrusion system,
and (iii) activation of Ca2 in£ux. Orrenius et al. [12]
hypothesized that the rise in cytosolic Ca2 level
stimulates endogenous endonuclease activity and ini-
tiates thymocyte apoptosis.
There is increasing evidence that the modulation of
the activity of protein kinase C (PKC) by a variety of
agents a¡ects the induction of apoptosis. PKC is a
serine/threonine protein kinase that consists of a
family of isoforms that show di¡erent Ca2 depend-
ence. Despite the evidence suggesting that PKC plays
a role in the regulation of apoptosis, there are con-
£icting results relating to PKC involvement in rescue
from apoptosis or the enhancement of the apoptotic
process. For example, stimulation of PKC by phor-
bol esters has been shown to block apoptosis due to
radiation [13] or glucocorticoids [14], while phorbol
esters alone or in combination with a calcium iono-
phore induce apoptosis in lymphoid cells [15]. Re-
cently, it has been reported that trimethyltin
(TMT), a member of the organotin family of com-
pounds, stimulates PKC activation and cell death,
while the PKC inhibitor chelerythrine provides pro-
tection against TMT-induced cytotoxicity in PC12
cells [16]. In view of the fact that TMT induces
PKC activation and cytotoxicity, it is possible that
TBT, a related compound, can also induce PKC ac-
tivation. However, the activation of PKC by TBT
and its involvement in the TBT-mediated apoptotic
process have never been demonstrated.
Previous work has shown that the ICE-like pro-
tease/ced-3 family, recently renamed the caspase fam-
ily, plays an important role in apoptosis and could
act upstream from the endonuclease. The caspase
family consists of at least ten related cysteine pro-
teases. All the caspases contain a conserved QACXG
(where X is R, Q or G) pentapeptide active-site motif
[17]. Activation of caspases during apoptosis results
in the cleavage of critical cellular substrates, such as
poly (ADP-ribose polymerase) (PARP) [18], nuclear
lamins [19], fodrin [20], histone H1 [21] and PKC N
[22]. Several other proteases involved in apoptosis
have also been identi¢ed, such as calpain, a Ca2-
dependent cysteine protease, serine protease [23],
granzyme B [24] and serpins [24].
Despite the fact that organotin compounds, and
especially TBT, are highly toxic water contaminants,
their mechanisms of toxicity are still poorly under-
stood. Since the rainbow trout is an organism that
has been extensively used in aquatic toxicity studies,
isolated trout hepatocytes have been employed to
study the e¡ects of TBT on cytosolic free calcium
[25,26]. However, the process of apoptosis, including
xenobiotic-induced apoptosis, has not been investi-
gated in rainbow trout. To our knowledge, apoptosis
in this organism has only been brie£y described [27].
The purpose of the present study was to determine
whether TBT induces apoptosis in trout hepatocytes,
and to examine the role of intracellular Ca2, PKC
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and proteases in apoptosis. We report here that TBT
treatment induces apoptosis in rainbow trout hepa-
tocytes. The ¢ndings suggest that Ca2 ions and
PKC play an important role in the pro-apoptotic
process induced by TBT. In addition, Z-VAD.FMK
is an extremely potent inhibitor of apoptosis; it is
likely that the activation of ICE-like proteases are
a key event in TBT-induced hepatocyte apoptosis.
Taken together, these data allow for the ¢rst time
to suggest a mechanistic model of TBT-induced
apoptosis. We propose that TBT could trigger apop-
tosis through a step involving Ca2 e¥ux from the
endoplasmic reticulum (ER) or other intracellular
pools and by mechanisms involving cysteine pro-
teases, such as calpains, as well as the phosphoryla-
tion status of apoptotic proteins such as Bcl-2 homo-
logues.
2. Materials and methods
2.1. Materials
The reagents used in this study were purchased as
follows: propidium iodide (PI), A23187 and phorbol-
12-myristate-13-acetate (PMA) from Calbiochem (La
Jolla, CA, USA); BAPTA-AM from Molecular
Probes (Junction City, OR, USA); staurosporine,
isoquinolinesulfonamide (H-7), N-ethylmaleimide
(NEM) and PMSF from Sigma (St. Louis, MO,
USA); TLCK from ICN (Mississauga, Canada);
tributyltin chloride (TBT) from Aldrich (Milwaukee,
WI, USA); Z-VAD.FMK, Ac.DEVD.CHO and Ac-
YVAD.CHO from BACHEM (Torrance, CA, USA).
The antibodies were obtained from Santa Cruz Bio-
technology (Santa Cruz, CA, USA).
2.2. Reagent stock solutions
Stock solutions of PI (2 mg/ml), H-7 (50 mM) and
chlorpromazine (40 mM) were prepared in water.
Stock solutions of BAPTA-AM (60 mM), A23187
(30 mM), staurosporine (0.5 mM), H-7 (50 mM)
and NEM (250 mM) were prepared in dimethyl sulf-
oxide (DMSO). TBT solutions (1, 2 and 2.5 mM)
were prepared in ethanol. The protease inhibitors
were prepared as follows: TLCK (10 mM), TPCK
(5 mM), Z.VAD.FMK (50 mM) and Ac-YVAD.-
CHO (100 mM) in DMSO, PMSF (100 mM) in
EtOH, and Ac.DEVD.CHO (6 mM) in Tris-HCl 50
mM pH 7.5.
2.3. Preparation of trout hepatocytes and exposure
to TBT
Hepatocytes were isolated from 250^300 g rain-
bow trout (Oncorhynchus mykiss) using the collagen-
ase perfusion method previously described [28].
Freshly isolated cells were distributed in culture
£asks (2U106 viable cells/ml) in modi¢ed Hanks’
bu¡er containing 120 mM NaCl, 5.4 mM KCl,
4.2 mM NaHCO3, 1.2 mM KH2PO4, 1.2 mM
MgSO4W7H2O, 15 mM glucose, 1.2 mM CaCl2W
2H2O, 20 mM HEPES and 0.05% albumin (pH 7.4).
The samples were incubated using an orbital shaker
at 50 rpm at room temperature. TBT was added to
the incubation medium to obtain nominal concentra-
tions of 1, 2, and 2.5 WM. Control cells were treated
with the vehicle (ethanol) alone. The diluent for TBT
(ethanol, ¢nal concentration 0.1%) had no detectable
e¡ect on the cells. In experiments carried out with
PKC inhibitors, the agents were added to the hepa-
tocyte suspension 1 h (staurosporine and H-7) or
20 min (BAPTA-AM) prior to the addition of
TBT. In studies involving the protease inhibitors
Z-VAD.FMK, Ac-YVAD.CHO and Ac-DEVD.
CHO, these compounds were added 1 h before
TBT addition, whereas NEM were added 20 min
prior TBT and TLCK, TPCK and PMSF were
added 5 min prior to TBT.
2.4. Flow cytometric analysis of viability
Viability of trout hepatocytes was monitored by
measurement of PI exclusion using £ow cytometry
(FCM) as described previously [25].
2.5. Measurement of DNA fragmentation
For detection of DNA fragmentation, 2 ml of cel-
lular suspension (2U106 cells/ml) were centrifuged at
350Ug for 2 min. The pellet was lysed in 50 Wl of a
bu¡er consisting of 50 mM Tris-HCl, 10 mM EDTA
and 0.5% SDS for 10 min at 55‡C. Thereafter, 10 Wl
of a solution of 20 mg/ml proteinase K was added.
The samples were left at 55‡C overnight and then
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10 Wl of a solution of 0.5 mg/ml RNase A was added
for 1 h at 37‡C. Thereafter, the samples were electro-
phoresed. Electrophoresis was performed at 100 V
for 3 h in 2% agarose gels with Tris-borate/EDTA
bu¡er (TBE). The DNA was visualized under UV
transillumination by ethidium bromide staining.
Figs. 1a, 2a,5A and 6 were obtained by scanning of
the respective photographs using an image scanner
(Hewlett Packard) and Adobe Photoshop 2.1 soft-
ware.
2.6. Fractionation of trout hepatocytes into membrane
and cytosol fractions
Ten ml of cellular suspension (2U106 cells/ml) were
centrifuged and the supernatant was replaced imme-
diately with 500 Wl of ice-cold PBS. The cells were
washed twice with PBS and resuspended in 200 Wl
of ice-cold homogenization bu¡er (20 mM Tris-
HCl; 2 mM EGTA; 2 mM EDTA; 6 mM L-mercap-
toethanol and 1.5 nM aprotinin, 10 nM leupeptin,
2.5 WM PMSF and 2.5 WM Na orthovanadate).
The cells were lysed by sonication (10 s burstU2).
The resulting cell lysate was centrifuged at
100 000Ug for 1 h at 4‡C using a Beckman optima
TLX ultracentrifuge. The supernatant was aspirated
and collected as the cytosol fraction. The resulting
pellet was resuspended in 100 Wl of homogenization
bu¡er to which NP-40 (¢nal concentration 1%, v/v)
was added. The samples were recentrifuged at
100 000Ug for 1 h at 4‡C to remove insoluble mem-
brane constituents. The cytosol and solubilized mem-
branes were used for Western blot. The protein con-
tents of the cytosol and membrane fractions were
determined by the Bradford’s method.
2.7. Western blot analysis of PKC isoforms:
PKC Q and PKC N
Membrane and cytosol fraction samples (50 Wg
protein) were prepared as above, mixed with Laemm-
li bu¡er, shaken for 10 min and heated to 100‡C by
incubating in a water bath for 4 min. 10% SDS-poly-
acrylamide gel electrophoresis (SDS-PAGE) was per-
formed at a constant voltage of 100 V for approx.
1.5 h. After SDS-PAGE, the proteins were trans-
ferred to a PVDF membrane; this was followed by
blocking of the non-speci¢c binding sites with a bu¡-
er containing 1% Tris-bu¡ered saline (2 mM Tris-
HCl, 13.7 mM NaCl, pH 7.6)+0.1% Tween 20
(TBST)+5% non-fat dry milk. This treatment was
performed overnight at 4‡C. The membranes were
then washed with TBST and incubated for 1 h at
room temperature with anti-PKC Q rabbit polyclonal
antibodies (diluted 1/3000 in TBST+1% BSA) or
anti-PKC N rabbit polyclonal antibodies (diluted
1/3000 in TBST+1% BSA). PKC Q and PKC N were
detected with goat anti-rabbit immunoglobulin G
(IgG) conjugated to horseradish peroxidase (diluted
1/5000 in TBST+5% non-fat dry milk) and chemilu-
minescent detection (ECL, Amersham, Bucks, UK)
[29,30]. The resulting membranes were exposed to
FUJI medical X-ray ¢lm. Densitometry assessment
of the bands was performed using the Molecular Dy-
namics scanner equipped with the analytical software
IP Lab gel.
2.8. Statistical analysis
Comparisons between groups were performed us-
ing ANOVA, and preplanned comparisons for spe-
ci¢c pairs of means were done with the contrast
statement in the SAS GLM procedure. P values
less than 0.05 were considered statistically signi¢-
cant.
3. Results
3.1. Time course of TBT-induced DNA fragmentation
and cell viability in trout hepatocytes
It has been previously demonstrated that TBT
stimulates apoptosis in rat thymocytes [8,31,32]. To
determine whether TBT also induces apoptosis in
trout hepatocytes, we measured DNA fragmentation
in cells treated with TBT. Apoptosis was identi¢ed
on the basis of the occurrence of internucleosomal
DNA cleavage on agarose gel electrophoresis. Gel
electrophoretic patterns of the DNA of TBT-treated
or untreated cells are shown in Fig. 1a. No internu-
cleosomal DNA cleavage was detectable in the con-
trol cells, while cells treated with 2 WM TBT for
90 min showed the DNA ladder pattern character-
istic of apoptosis. At 1 WM, TBT did not promote
DNA fragmentation even when the treatment was
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prolonged to 180 min (data not shown), while weak
ladder staining was observed after 90 min of expo-
sure to 2.5 WM TBT.
In parallel experiments, the PI uptake technique
was applied using FCM. PI uptake re£ects the loss
of membrane integrity and cellular viability. Trout
hepatocytes were exposed to 1, 2 and 2.5 WM TBT,
and PI uptake was monitored by FCM after 30, 90
and 180 min of incubation. As shown in Fig. 1b,
exposure to 2 WM TBT for 90 min, representing
the conditions where apoptotic DNA fragmentation
has been observed, causes a slight decrease in cell
viability. The e¡ect was concentration- and time-de-
pendent. At the lowest concentration (1 WM), TBT
did not a¡ect cell viability up to 180 min (data not
shown), while at the highest concentration (2.5 WM),
TBT caused cell death as rapidly as after 30 min of
incubation (Fig. 1b). PI staining at 2.5 WM TBT and
the fact that only weak ladder staining has been
observed under this condition suggest a cell death
by necrosis rather than apoptosis. Since no DNA
fragmentation nor important loss of viability was
observed after 30 min exposure to either 1, 2 or
2.5 WM TBT, this exposure time was omitted in the
experiments that followed.
3.2. Role of Ca2 signaling on TBT-induced DNA
fragmentation and cell viability
The biochemical pathways that lead to cell death
by apoptosis are complex, but growing evidence sug-
gests that the increase in [Ca2]i plays a key role in
apoptosis by activating an endogenous Ca2-depend-
ent endonuclease. We have previously reported that
TBT causes a rapid and sustained elevation of
[Ca2]i in isolated trout hepatocytes [25,26]. To in-
vestigate the possible involvement of an increase in
[Ca2]i in TBT-mediated DNA cleavage, we per-
formed two di¡erent series of experiments. Trout
hepatocytes were loaded with the Ca2 chelator
BAPTA-AM and subsequently incubated with
TBT. Fig. 2 shows that the presence of BAPTA-
AM has a suppressive e¡ect on TBT-mediated
DNA fragmentation (Fig. 2a) and has a protective
e¡ect on loss of plasma membrane integrity (Fig.
2b,c). We next examined whether an increase in
[Ca2]i induced by the Ca2 ionophore A23187
would cause apoptosis in trout hepatocytes. As
shown in Fig. 2a, exposure of cells to 1, 10 and
30 WM A23187 did not induce DNA fragmentation
after 90 min of treatment. Although the presence of
BAPTA-AM in cells blocks apoptosis induced by
TBT, exposure to the ionophore A23187 fails to
stimulate apoptosis in trout hepatocytes.
Fig. 1. DNA fragmentation and cell viability of trout hepato-
cytes exposed to TBT. (a) Dose-response of DNA fragmenta-
tion visualized as oligonucleosome-size fragments stained with
ethidium bromide in agarose gels. DNA was prepared from
samples incubated with TBT for 30 and 90 min and analyzed
according to the protocol described in Section 2. LAMbdA-
HindIII is the standard used. (b) Time course of cell viability
after TBT treatment. Viability of trout hepatocytes was moni-
tored by £ow cytometry measurement of PI exclusion at 30, 90
and 180 min. Cell viability was expressed as the percentage of
cells that exclude PI. The data are means þ S.E. of three sepa-
rate cell preparations. *Signi¢cantly di¡erent from controls at
P6 0.05.
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3.3. Protein kinase C activity in trout hepatocyte
exposed to TBT
PKC is an important component of the intra-cy-
toplasmic and nuclear signal transduction pathways
believed to be involved in the regulation of apopto-
sis. PKC translocation from the cytosol to cellular
membranes is associated with activation of the en-
zyme. It has been shown that inhibition/activation of
PKC can both induce and suppress apoptosis [33,34].
In order to investigate the action of TBT on PKC in
trout hepatocytes, PKC Q and PKC N translocation
from the cytosol to cellular membranes were ana-
lyzed. We performed quantitative Western blot anal-
ysis using trout hepatocytes exposed to TBT (2 and
2.5 WM) for 30 and 90 min (Fig. 3a,b). After 30 min
of TBT treatment at 2 and 2.5 WM, we observed a
translocation of PKC Q to hepatocyte membranes
(Fig. 3a). Densitometric analysis revealed that after
30 min of TBT treatment, there was an increase in
membrane-associated PKC above the control value
(set as 100%) to 175% at 2 WM TBT and to 130% at
2.5 WM (Fig. 4a). However, we observed that PKC Q
translocation was down-regulated after 90 min of
treatment. At this time, the values fall below that
of controls, namely 60% and 10%, for 2 and 2.5 WM
TBT respectively (Fig. 4a). The other PKC isoform,
PKC N, showed a somewhat di¡erent activation pat-
tern. TBT treatment at 2 and 2.5 WM induced a
translocation of PKC N from the cytosol to mem-
branes after 30 min of treatment (Fig. 3b). The re-
sults obtained by densitometric analysis show an in-
crease in membrane-associated PKC N above control
values to 220% and 500%, respectively, after 30 min
of TBT exposure (Fig. 4b). The membrane-associ-
ated PKC N was maintained after 90 min of treat-
ment at 2 WM TBT, whereas the values fall slightly
after 90 min of treatment at 2.5 WM TBT (390%)
(Fig. 4b). In these experiments, PMA which induced
PKC activity has been used as a positive control.
Previous work has provided evidence that phos-
phorylation/dephosphorylation is required for apop-
tosis [35^39]. An increase in PKC activity induced by
TBT exposure may be a trigger for apoptosis in trout
Fig. 2. DNA fragmentation and cell viability of trout hepatocytes pre-incubated with BAPTA-AM and exposed to TBT or treated
with A23187. (a) E¡ects of the Ca2 chelator BAPTA-AM and the ionophore A23187 on DNA fragmentation visualized as oligonu-
cleosome-size fragments stained with ethidium bromide in agarose gels. Trout hepatocytes were loaded with 60 WM BAPTA-AM for
20 min and then treated with 1, 2 and 2.5 WM of TBT for 90 min. In the experiment with A23187, the cells were treated for 90 with
1, 10 or 30 WM A23187. DNA was prepared and analyzed according to the protocol described in Section 2. LAMbdA-HindIII is the
standard used. Viability of BAPTA-loaded cells was monitored by £ow cytometry measurement of PI exclusion after 90 and 180 min
of (b) 2 WM and (c) 2.5 WM TBT exposure. Cell viability was expressed as the percentage of cells that exclude PI. The data are means
þ S.E. for three experiments on di¡erent cell preparations. *Signi¢cantly di¡erent from TBT alone at P6 0.05.
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hepatocytes. To determine whether protein phos-
phorylation/dephosphorylation plays a role in TBT-
induced DNA fragmentation, the cells were treated
with agents known to inhibit (staurosporine and
H-7) or induce (PMA) PKC activity. First, the cells
were pre-treated with staurosporine or H-7 for 60 min
prior to the addition of TBT. After 90 min of treat-
ment with TBT, the cells were assayed for DNA
fragmentation and viability. The inhibitors have
been used at the highest concentrations that could
be applied without causing loss of viability. As
shown in Fig. 5a, neither 0.5 WM staurosporine nor
50 WM H-7 reduced the DNA fragmentation induced
by TBT treatment. On the contrary, both PKC in-
hibitors enhanced DNA fragmentation. Indeed, after
90 min of treatment at 2.5 WM TBT, there is a more
pronounced DNA fragmentation in cells pre-treated
with staurosporine and H-7 than in those without the
pre-treatment. None of the inhibitors alone a¡ected
DNA fragmentation in control cells (Fig. 5A). Sec-
Fig. 3. Western blot of TBT-induced PKC Q (a) and PKC N (b) translocation from cytosol to cellular membrane in trout hepatocytes.
Trout hepatocytes were exposed in the presence (2 and 2.5 WM) and absence (control) of TBT for 90 min. Fractionation of cells and
Western blot analysis were performed as described in Section 2. PMA has been used as a positive control. The data demonstrate a
single Western blot representative of two separate experiments. c, cytosol ; m, cellular membranes.
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ond, we examined whether an increase in PKC activ-
ity by PMA, a well known PKC activator, induces
apoptosis in trout hepatocytes. The cells were ex-
posed to 1 WM of PMA for 90 min. The results
obtained show that exposure of hepatocytes to
PMA resulted in a translocation of PKC Q and N
from cytosol to the cellular membranes (Fig. 3a,b)
but the translocation of PKC failed to stimulate
DNA fragmentation in trout hepatocytes (Fig. 5a).
Cell viability was assessed under the exposure con-
ditions used for analysis of DNA fragmentation. Fig.
5b and c show that staurosporine H-7 protected
against loss of cell viability, as seen by the reduction
in PI uptake produced by 2 WM and 2.5 WM TBT
after 180 min of treatment: about 20 and 40%, re-
spectively, for staurosporine, and 20 and 50%, re-
spectively, for H-7, as compared to cells treated
with staurosporine or H-7 alone.
3.4. E¡ects of protease inhibitors on TBT-induced
apoptosis
To further investigate the mechanism of TBT-in-
duced apoptosis, we examined the e¡ects of various
protease inhibitors. These include Ac-YVAD.CHO,
a speci¢c ICE (or caspase 1) inhibitor; Ac-DEVD.-
CHO, a potent inhibitor of CPP32 and Mch3K (or
caspase 3 and 7, respectively); Z-VAD.FMK, a more
potent ICE-like protease inhibitor but less speci¢c
for ICE itself ; TPCK, TLCK and PMSF, three ser-
ine protease inhibitors; and NEM, a cysteine pro-
tease inhibitor. TPCK, TLCK, PMSF, Ac-Y-VAD.-
CHO and Ac-DEVD.CHO, had no e¡ect on TBT-
induced DNA fragmentation and all fail to inhibit PI
uptake induced by TBT (Table 1). In contrast, the
caspase inhibitor Z-VAD.FMK, and the cysteine
protease inhibitor NEM, prevented DNA fragmenta-
tion induced by TBT (Fig. 6) but only NEM had a
protective e¡ect on cell viability (Table 1).
4. Discussion
During the last decade, interest in apoptosis has
increased signi¢cantly, in great part due to the fact
that its deregulation may have important implica-
tions on immune system disorders and carcinogene-
sis. However, apoptosis in the liver has not been
extensively studied and almost no attention has
been devoted to ¢sh cells. To our knowledge, apop-
tosis has been previously observed only in the gills of
rainbow trout [27]. This report provides evidence
that TBT can stimulate apoptosis in rainbow trout
hepatocytes. After 90 min of treatment at 2 WM,
TBT preferentially promotes DNA fragmentation
without signi¢cant loss of plasma membrane integ-
rity, whereas at 2.5 WM, TBT causes a signi¢cant loss
of viability with only a weak DNA ladder (Fig. 1).
It has been reported that TBT induces apoptosis in
thymocytes and that a rise in cytosolic Ca2 level is
implicated in TBT-stimulated apoptosis in these cells
[31,32,40]. Orrenius et al. [12] have hypothesized that
the sustained elevation of cytosolic Ca2 triggered by
TBT stimulates an endonuclease activity and initiates
thymocyte apoptosis. In line with these observations,
we have previously reported that micromolar concen-
trations of TBT cause a rapid and sustained increase
in the cytosolic free calcium concentration in trout
hepatocytes [25,26]. We now show that an elevation
of cytosolic Ca2 is associated with extensive DNA
fragmentation in trout hepatocytes since DNA cleav-
age is prevented by cells pre-treatment with the intra-
cellular Ca2 chelator BAPTA-AM (Fig. 2a). These
results suggest that an increase in intracellular Ca2
is a key event in TBT-mediated apoptosis in trout
Fig. 4. Densitometric analysis of PKC Q (a) and PKC N (b) ex-
pression. The 80 kDa bands corresponding to PKC isoforms Q
and N identi¢ed by Western blotting in Fig. 3 were analyzed us-
ing quantitative densitometry as described in Section 2. Results
are expressed in percentage PKC signal of corresponding bands
from membranes of control cells (treated with vehicle only).
Data are representative of two separate experiments.
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hepatocytes. However, an increase in Ca2 alone
does not seem to be su⁄cient to promote apoptosis
in hepatocytes since treatment of hepatocytes with
the Ca2 ionophore A23187 fails to promote apop-
tosis (Fig. 2a). Accordingly, TBT could trigger apop-
tosis by mobilizing Ca2 from internal stores which
is further supported by our previous demonstration
that the increase of cytosolic Ca2 in trout hepato-
cytes exposed to TBT mainly involves an intracellu-
lar pool, probably that of ER [26]. It has also been
shown by others that TBT releases a 2,5-di(terbutyl)-
1,4-benzohydroquinone (t-BuBHQ)-sensitive Ca2
pool, t-BuBHQ being known to empty the agonist-
sensitive ER Ca2 store [11].
Fig. 5. DNA fragmentation and cell viability of trout hepatocytes pre-incubated with protein kinase inhibitors and subsequently
treated with TBT or treated with PMA. (A) E¡ects of protein kinase inhibitors on DNA fragmentation induced by TBT visualized as
oligonucleosome-size fragments stained with ethidium bromide in agarose gels. Trout hepatocytes were incubated with staurosporine
(0.5 WM) or H-7 (50 WM) for 1 h and subsequently treated with 1, 2 and 2.5 WM of TBT for 90 min or exposed to 1 WM of PMA
alone for 90 min. DNA was prepared from samples incubated with TBT and analyzed according to the protocol described in Section
2. LAMbdA-HindIII is the standard used. Viability of cells was monitored by £ow cytometry measurement of PI exclusion after 90
and 180 min of (b) 2 WM and (c) 2.5 WM TBT exposure. Cell viability was expressed as the percentage of cells that exclude PI. The
data are means þ S.E. for three experiments on di¡erent cell preparations. *Signi¢cantly di¡erent from TBT alone at P6 0.05.
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Considering the importance of mobilization of
ER-associated Ca2 in the mechanism that triggers
apoptosis, the results obtained with the ionophore
A23187 can be explained by the primary action of
this ionophore on the cytoplasmic membrane [41].
Therefore, A23187 stimulates Ca2 in£ux from the
extracellular media but, under our experimental con-
ditions, fails to deplete ER calcium store contrary to
the suggested action of TBT. Previously, Lam et al.
[42] have shown that thapsigargin (Tg), which inhib-
its ER-associated Ca2-ATPase and thereby mobi-
lizes Ca2 from ER-associated stores and subse-
quently stimulates capacitative Ca2 entry, induces
DNA fragmentation in mouse lymphoma cells. Con-
sistently with the view that Ca2 is involved in the
signaling pathways of DNA fragmentation, they
have hypothesized that mobilization of ER-associ-
ated Ca2 may be a critical step in the process that
triggers the programmed cell death of lymphocytes.
Similarly, Jiang et al. [43] have also demonstrated
Fig. 6. DNA fragmentation of trout hepatocytes pre-incubated with NEM or Z-VAD.FMK and exposed to TBT. E¡ects of proteases
inhibitors on DNA fragmentation induced by TBT visualized as oligonucleosome-size fragments stained with ethidium bromide in
agarose gels. Trout hepatocytes were incubated with NEM (250 WM) for 20 min or with Z-VAD.FMK (50 WM) for 1 h and subse-
quently treated with 1, 2 and 2.5 WM of TBT for 90 min. DNA was prepared from samples incubated with TBT and analyzed accord-
ing to the protocol described in Section 2. LAMbdA-HindIII is the standard used. The data demonstrate a single gel representative of
three separate experiments.
Table 1
Evaluation of di¡erent protease inhibitors on DNA fragmentation and cell viability of trout hepatocytes exposed to TBT
Inhibitors Concentration
(WM)
Predicted enzyme
speci¢city
Modulation of TBT-induced
DNA fragmentation*
Protective e¡ect against
TBT cytotoxicity
TLCK 10 Serine protease = No
TPCK 5 Serine protease = No
PMSF 100 Serine protease = No
N-Ethylmaleimide 250 Cysteine protease 3 Yes
Z-VAD.FMK 50 ICE-like protease 3 No
Ac-YVAD.CHO 100 ICE = No
Ac-DEVD.CHO 6 CPP32/Mch3a = No
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that Tg-induced cytosolic Ca2 increase can trigger
thymocyte apoptosis and that the irreversible empty-
ing of intracellular Ca2 pools seems to be determi-
nant in the activation of apoptosis.
PKC is one of the known regulators of cellular
apoptosis [33]. It has been suggested that inhibi-
tion/activation of PKC can both induce and suppress
apoptosis. Our results show that the implication of
PKC in the cellular response to TBT exposure is
complex. TBT induced PKC Q and N translocation
from cytosol to the cellular membrane (after 30 min
of exposure) but it also caused a down-regulation or
degradation of PKC Q occurring after activation of
the enzyme (Fig. 3). However, the current results
demonstrate that pre-treatment with protein kinase
inhibitors fails to block apoptosis in TBT-treated
hepatocytes. On the contrary, pre-treatment with
staurosporine and H-7 promoted a stronger DNA
fragmentation in cells exposed to 2.5 WM TBT and
protected membrane integrity (Fig. 5A,c). In addi-
tion, the absence of DNA fragmentation after
PMA treatment, a direct activator of PKC activity,
suggests that one of the key events in the signaling
cascade of TBT-induced apoptosis in trout hepato-
cytes is not the translocation of PKC to the mem-
brane but rather the down-regulation or the degra-
dation of certain PKC isoforms such as PKC Q.
Although it is well known that PKC plays a role in
apoptosis, the mechanisms by which PKC isoforms
mediate their e¡ects on the apoptotic process are not
well established. May et al. [44] have found that Bcl-
2, a protein of 25^26 kDa located in ER membrane
[38], is rapidly hyperphosphorylated exclusively at
serine residues by interleukin-3 (IL-3) and bryosta-
tin-1 (bryo) (an activator of PKC) in association with
suppression of apoptosis in murine myeloid factor-
dependent FDC-P1/ER cells. The PKC inhibitors
staurosporine and H-7 block IL-3 and bryo-induced
hyperphosphorylation of Bcl-2 and their anti-apop-
totic e¡ect, suggesting a regulatory role for activated
PKC in both processes [44]. In addition, Korsmeyer’s
group has recently shown that phosphorylation of
the Bcl-2 homologue, Bad, is linked to the activity
of survival factors [45]. Non-phosphorylated Bad
heterodimerizes with Bcl-xL or Bcl-2, neutralizing
their protective e¡ect and promoting cell death,
whereas phosphorylated Bad was sequestered in the
cytosol bound to 14-3-3 [45]. Thus, our results show-
ing that the protein kinase inhibitors staurosporine
and H-7 enhance TBT-induced apoptosis (Fig. 5a)
agree with the view that down-regulation or degra-
dation of certain PKC isoforms such as PKC Q help
promote TBT-induced apoptosis in trout hepato-
cytes. Down-regulation or degradation of PKC Q
could act by preventing Bcl-xL phosphorylation itself
(Bcl-xL being present in trout hepatocytes, data not
shown) or other Bcl-2 homologues like Bad, and in
this way, promote cell death.
To gain further insights into the pathway of TBT-
induced apoptosis, the DNA fragmentation induced
by TBT was studied in the presence of protease in-
hibitors. There is emerging evidence that caspases
have been implicated as the key enzymes involved
in the execution of apoptosis. Our results show that
Z-VAD.FMK is an extremely potent inhibitor of
apoptosis (Fig. 6); it is likely that the activation of
ICE-like proteases is a key event in TBT-induced
hepatocyte apoptosis. We have also found that Ac-
YVAD.CHO and Ac-DEVD.CHO, inhibitors specif-
ic for ICE and CPP32 respectively, are both ine¡ec-
tive at inhibiting TBT-induced apoptosis (Table 1).
The lack of e¡ect of Ac-YVAD.CHO and Ac-
DEVD.CHO inhibitors suggests that ICE and
CPP32 are not activated in the apoptotic mechanism
induced by TBT.
The precise identi¢cation of the proteases impli-
cated in the pro-apoptotic process induced by TBT
is as yet unresolved. The results obtained with NEM
and Z-VAD.FMK show that a cysteine protease
could be involved. Consistent with our present re-
sults, it is tempting to postulate that calpains, which
are Ca2-dependent cysteine proteases, could play a
role in the signaling cascade of TBT-induced apop-
tosis in trout hepatocytes. Some emerging work has
shown that calpain activity triggered apoptosis. We
and others have demonstrated that TBT causes a
rapid and important elevation in intracellular Ca2.
Thus, TBT could stimulate calpain activity by induc-
ing an increase in intracellular Ca2 in trout hepato-
cytes.
Calpains do not cause a general degradation of
cellular proteins but rather elicit a limited cleavage
of substrates, and in many instances activate many
cellular systems [24]. It is now recognized that cal-
pains cleave the cytoskeletal actin binding protein
K-fodrin (non-erythroid spectrin), an abundant mem-
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brane associated cytoskeletal protein cleaved during
apoptosis [24]. Another well-known calpain substrate
is PKC Q. It is therefore possible that the PKC Q
down-regulation observed during TBT treatment
may be caused by calpain activity. Furthermore, re-
cent studies have shown that PKC N is selectively
cleaved to a catalytically active fragment in cells by
an ICE/CED-3 like protease to undergo apoptosis
[22,46]. However, the previous phenomenon is not
supported because PKC N is not down-regulated or
cleaved during TBT-induced apoptosis in trout hep-
atocytes.
Taken together, these data allow for the ¢rst time
to suggest a mechanistic model of TBT-induced
apoptosis. We propose that TBT could trigger apop-
tosis through a step involving Ca2 e¥ux from the
ER or other intracellular pools. The rise in intracel-
lular calcium could activate an endonuclease, result-
ing in fragmentation of DNA. Increased intracellular
Ca2 levels also activate calpain-like proteases which
down-regulate or degrade PKC Q, a well-known cal-
pain substrate. The down-regulation or degradation
of PKC Q, a key event in TBT-induced apoptosis,
could modify the phosphorylation status of apop-
totic proteins such as Bcl-2 homologues and lead to
apoptosis in trout hepatocytes.
Acknowledgements
The authors would like to thank Julie Poirier for
her technical assistance, and Dr. Catherine Jumarie
and Dr. Jacques Bernier for helpful discussions. This
work was supported by the Natural Sciences and
Engineering Research Council of Canada and FO-
DAR (Fonds de De¤veloppement Acade¤mique du Re¤-
seau de l’Universite¤ du Que¤bec).
References
[1] A.H. Wyllie, J.F.R. Kerr, A.R. Cumi, Int. Rev. Cytol. 68
(1980) 251^306.
[2] A.H. Wyllie, Nature 284 (1981) 555^556.
[3] R.E. Ellis, J. Yuan, H.R. Horvitz, Annu. Rev. Cell Biol. 7
(1991) 663^698.
[4] J. Yuan, H.R. Hortvitz, Dev. Biol. 138 (1990) 33^41.
[5] J. Yuan, S. Shaham, S. Ledoux, H.M. Ellis, H.R. Hortvitz,
Cell 75 (1993) 641^652.
[6] G. Majno, I. Joris, Am. J. Pathol. 146 (1995) 3^15.
[7] F.L. Bygrave, Biochem. J. 170 (1978) 87^91.
[8] M. Ra¡ray, G.M. Cohen, Arch. Toxicol. 67 (1993) 231^
236.
[9] B. Viviani, A.D. Rossi, S.C. Chow, P. Nicotera, NeuroTox-
icology 16 (1995) 19^26.
[10] R. Batel, N. Bihari, B. Rinkevich, J. Dapper, H. Scha«cke,
H.C. Schro«der, W.E.G. My«ller, Mar. Ecol. Prog. Ser. 93
(1993) 245^251.
[11] S.C. Chow, G.E.N. Kass, M.J. McCabe Jr, S. Orrenius,
Arch. Biochem. Biophys. 298 (1992) 143^149.
[12] S. Orrenius, M.J. McCabe Jr., P. Nicotera, Toxicol. Lett. 64/
65 (1992) 357^364.
[13] L.D. Tomei, P. Kanter, C.E. Wenner, Biochem. Biophys.
Res. Commun. 155 (1988) 324^331.
[14] F. Ojeda, M. Guarda, C. Maldonado, H. Frolch, Cell Im-
munol. 125 (1990) 535^539.
[15] M. Mercep, P.D. Noguchi, J.D. Ashwell, J. Immunol. 142
(1989) 4085^4092.
[16] G. Pavlakovic, M.D.K. Kane, C.L. Eyer, A. Kanthasamy,
G.E. Isom, J. Neurochem. 65 (1995) 2338^2343.
[17] G.M. Cohen, Biochem. J. 326 (1997) 1^16.
[18] Y. Lazebnik, S. Kaufmann, S. Desnoyer, G. Poirier, W.
Earnshaw, Nature 371 (1994) 346^347.
[19] Y.A. Lazebnik, S. Cole, C.A. Cooke, W.G. Nelson, W.C.
Earnshow, J. Cell Biol. 123 (1993) 7^22.
[20] S.J. Martin, G.A. O’Brien, W.K. Nishioka, A.J. McGahon,
A. Mahboubi, T.C. Saido, D.R. Gree, J. Biol. Chem. 270
(1995) 6425^6428.
[21] A.I. Gaziev, M.P. Kutsyi, Int. J. Radiat. Biol. 61 (1992) 169^
174.
[22] Y. Emoto, Y. Manome, G. Meinhardt, H. Kisaki, S. Khar-
banda, M. Robertson, T. Ghayur, W.W. Wong, R. Kamen,
R. Weichselbaum, D. Kufe, EMBO J. 14 (1995) 6148^6156.
[23] M. Squier, A. Miller, A. Malkinson, J. Cohen, J. Cell. Phys-
iol. 159 (1994) 229^237.
[24] B. Zhivotovsky, D.H. Burgess, D.M. Vanags, S. Orrenius,
Biochem. Biophys. Res. Commun. 230 (1997) 481^488.
[25] S. Reader, M. Marion, D. Denizeau, Toxicology 80 (1993)
117^129.
[26] S. Reader, H.B. Steen, F. Denizeau, Arch. Biochem. Bio-
phys. 312 (1994) 407^413.
[27] P.-Y. Daoust, G. Wobeser, J.D. Newstead, Vet. Pathol. 21
(1984) 93^101.
[28] F. Denizeau, M. Marion, Can. J. Aquat. Sci. 47 (1990)
1038^1042.
[29] R. Maroto, J.R. Perez-Polo, J. Neurochem. 69 (1997) 514^
523.
[30] H. Kurosawa, F.G. Que, L.R. Roberts, P.J. Fesmier, G.J.
Gores, Am. J. Physiol. Gatrointest. Liver Physiol. 35 (1997)
G1587^G1593.
[31] T.Y. Aw, P. Nicotera, L. Manzo, S. Orrenius, Arch. Bio-
chem. Biophys. 283 (1990) 46^50.
[32] M. Ra¡ray, D. McCarthy, R.T. Snowden, G.M. Cohen,
Toxicol. Appl. Pharmacol. 119 (1993) 122^130.
[33] D. Leszczynski, Cancer J. 9 (1996) 308^313.
BBAMCR 14430 5-1-99
S. Reader et al. / Biochimica et Biophysica Acta 1448 (1999) 473^485484
[34] B.A. Jones, Y.-P. Rao, R.T. Stravitz, G.J. Gores, Am. J.
Physiol. Gatrointest. Liver Physiol. 35 (1997) G1109^G1115.
[35] M. Lucas, V. Sanchez-Margalet, Gen. Pharmacol. 26 (1995)
881^887.
[36] B.T. Gjertsen, S.O. Doskeland, Biochim. Biophys. Acta 1269
(1995) 187^199.
[37] C.-Y. Chen, D.V. Faller, J. Biol. Chem. 271 (1996) 2376^
2379.
[38] S. Haldar, J. Chintapalli, C.M. Croce, Cancer Res. 56 (1996)
1253^1255.
[39] Y. Itano, A. Ito, T. Uehara, Y. Nomura, J. Neurochem. 67
(1996) 131^137.
[40] R.M. Zucker, K.H. Elstein, D.J. Thomas, J.M. Rogers, Tox-
icol. Appl. Pharmacol. 127 (1994) 163^170.
[41] P.R. Albert, A.H. Tashijian, Am. J. Physiol. 251 (1986)
C887^C891.
[42] M. Lam, G. Dubyak, C.W. Distelhorst, Mol. Endocrinol. 7
(1993) 686^693.
[43] S. Jiang, S.C. Chow, P. Nicotera, S. Orrenius, Exp. Cell Res.
212 (1994) 84^92.
[44] W.S. May, P.G. Tyler, T. Ito, D.K. Armstrong, K.A. Qat-
sha, N.E. Davidson, J. Biol. Chem. 269 (1994) 26865^26870.
[45] J. Zha, H. Harada, E. Yang, J. Jockel, S.J. Korsmeyer, Cell
87 (1996) 619^628.
[46] T. Ghayur, M. Hugunin, R.V. Talanian, S. Ratnofsky, C.
Quinlan, Y. Emoto, P. Pandey, R. Datta, Y. Huang, S.
Kharbanda, H. Allen, R. Kamen, W. Wong, D. Kufe,
J. Exp. Med. 184 (1996) 2399^2404.
BBAMCR 14430 5-1-99
S. Reader et al. / Biochimica et Biophysica Acta 1448 (1999) 473^485 485
